William M Gallagher Selected Research

William M Gallagher Research Topics

Disease

68	Neoplasms (Cancer) 01/2022 - 12/2004
55	Breast Neoplasms (Breast Cancer) 10/2022 - 08/2005
16	Melanoma (Melanoma, Malignant) 01/2022 - 11/2005
12	Neoplasm Metastasis (Metastasis) 10/2022 - 04/2007
12	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 07/2011
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2011
8	Triple Negative Breast Neoplasms 04/2020 - 04/2014
6	Inflammation (Inflammations) 01/2021 - 01/2011
4	Hypoxia (Hypoxemia) 01/2019 - 11/2006
3	Carcinoma (Carcinomatosis) 02/2022 - 09/2004
3	Disease Progression 01/2021 - 02/2010
3	Ovarian Neoplasms (Ovarian Cancer) 10/2014 - 09/2011
3	Hyperplasia 06/2006 - 03/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 04/2007
2	Carcinogenesis 12/2021 - 01/2021
2	Ovarian Epithelial Carcinoma 09/2011 - 05/2009
1	Lymphatic Metastasis 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenoma (Adenomas) 12/2021
1	Dysbiosis 01/2021
1	Uveal melanoma 10/2020
1	Obesity 09/2020
1	Endometrial Neoplasms (Endometrial Cancer) 09/2020

Drug/Important Bio-Agent (IBA)

42	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2007
29	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2007
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2005
10	Estrogen ReceptorsIBA 01/2022 - 11/2006
9	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2008
8	Pharmaceutical PreparationsIBA 01/2018 - 02/2007
7	Messenger RNA (mRNA)IBA 02/2022 - 11/2005
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 09/2011
5	Serum Response FactorIBA 01/2022 - 05/2013
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2010
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2011
4	EnzymesIBA 04/2020 - 04/2010
4	Bevacizumab (Avastin)FDA Link 01/2020 - 06/2017
4	Biological ProductsIBA 06/2015 - 04/2007
4	ProteomeIBA 01/2015 - 02/2007
3	Small Interfering RNA (siRNA)IBA 02/2022 - 09/2009
3	Formaldehyde (Formol)FDA Link 01/2022 - 07/2017
3	ParaffinIBA 01/2022 - 07/2017
3	AcidsIBA 12/2021 - 04/2013
3	human ERBB2 proteinIBA 11/2021 - 10/2010
3	Lapatinib (GW572016)FDA Link 01/2021 - 10/2011
3	Peptides (Polypeptides)IBA 06/2015 - 04/2013
3	Tamoxifen FDA LinkGeneric 01/2011 - 05/2009
3	SurvivinIBA 11/2010 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 10/2010
2	Hormones (Hormone)IBA 01/2021 - 05/2013
2	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 11/2015
2	AntioxidantsIBA 04/2020 - 07/2014
2	quininibIBA 06/2019 - 10/2016
2	Sunitinib (Sutent)FDA Link 01/2019 - 01/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2018 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 03/2018 - 01/2016
2	PolyhydroxyalkanoatesIBA 06/2015 - 04/2013
2	Complement System Proteins (Complement)IBA 06/2015 - 11/2011
2	Phenobarbital (Luminal)FDA Link 10/2013 - 01/2013
2	AntibodiesIBA 04/2013 - 01/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2012 - 09/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2012 - 09/2011
2	ChemokinesIBA 01/2012 - 09/2011
2	CytokinesIBA 01/2012 - 09/2011
2	SOXC Transcription FactorsIBA 09/2011 - 05/2009
2	Oxygen (Dioxygen)IBA 09/2011 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 04/2011 - 04/2007
2	Oxidoreductases (Dehydrogenase)IBA 01/2011 - 04/2010
2	Indicators and Reagents (Reagents)IBA 11/2010 - 05/2008
2	A-Form DNA (A-DNA)IBA 10/2010 - 09/2008
2	Cyclin EIBA 04/2007 - 11/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	Gemcitabine FDA Link 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	lestaurtinibIBA 01/2022
1	propionic acid (potassium propionate)IBA 12/2021
1	2-methylbutanoic acidIBA 12/2021
1	Volatile Fatty AcidsIBA 12/2021
1	n-pentanoic acid (valeric acid)IBA 12/2021
1	UbiquitinIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	AfatinibIBA 01/2021
1	neratinibIBA 01/2021
1	pertuzumabIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	enzalutamideIBA 11/2020
1	Deubiquitinating EnzymesIBA 11/2020
1	venetoclaxIBA 10/2020
1	AS 8IBA 10/2020
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020

Therapy/Procedure

32	Therapeutics 01/2022 - 02/2006
10	Drug Therapy (Chemotherapy) 02/2022 - 11/2005
3	Neoadjuvant Therapy 05/2020 - 02/2007
3	Castration 02/2014 - 10/2011
2	Immunotherapy 01/2022 - 01/2018
2	Prostatectomy (Retropubic Prostatectomy) 11/2015 - 05/2011
2	Photochemotherapy (Photodynamic Therapy) 02/2012 - 09/2009
2	Stents 06/2006 - 04/2004
1	Cystectomy 02/2022
1	Traction 10/2020